DCDQ
DCDQ is a potent acetylcholinesterase (AChE) inhibitor. DCDQ shows a strong binding affinity with the 4EY7 protein (binding energy: −8.2 kcal/mol) . DCDQ is promising for research of Alzheimer's disease (AD) [1].
Product Specifications
CAS Number
27631-29-4
UNSPSC
12352005
Target
Cholinesterase (ChE)
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Purity
99.94
Solubility
DMSO : 16.67 mg/mL (ultrasonic)
Smiles
ClC1=NC2=C(C=C(C(OC)=C2)OC)C(Cl)=N1
Molecular Formula
C10H8Cl2N2O2
Molecular Weight
259.09
References & Citations
[1]Asokan K, et al. Spectroscopic, DFT, In Silico, and Estimation of Biological Activity of 2, 4‐Dichloro‐6, 7‐Dimethoxyquinazoline as a Potential Anti‐Alzheimer's Disease Therapeutic Agent[J]. International Journal of Quantum Chemistry, 2025, 125 (1) : e70006.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
